Travoprost-Mepha Plus 0.04mg/5mg

Travoprost-Mepha Plus 0.04mg/5mg is a medicine authorised by Swissmedic under authorisation number 66730. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 January 2019 and the authorisation is limited until 01 September 2026. ATC code S01ED51 places the medicine in the group Ophthalmologicals.

  • Dispensing category B
  • Authorisation number 66730
  • ATC S01ED51
  • Synthetic medicines
Authorisation data
Authorisation number66730
NameTravoprost-Mepha Plus 0.04mg/5mg
Full nameTravoprost-Mepha Plus 0.04mg/5mg, Augentropfen
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeS01ED51
First authorisation31 January 2019
Authorisation validity01 September 2026
Strengths
No.NameDispensing categoryAuthorisation date
1Travoprost-Mepha Plus 0.04mg/5mg, AugentropfenB31 January 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12,5mlS01ED5111.09.0.B
23 x 2,5mlS01ED5111.09.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Travoprost-Mepha Plus 0.04mg/5mg authorised in Switzerland?

Yes. Travoprost-Mepha Plus 0.04mg/5mg is authorised by Swissmedic under authorisation number 66730, data as of 01 September 2026. The authorisation is limited until 01 September 2026.

Which dispensing category does Travoprost-Mepha Plus 0.04mg/5mg have?

Travoprost-Mepha Plus 0.04mg/5mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Travoprost-Mepha Plus 0.04mg/5mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com